W Warren Suh

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer
    W Warren Suh
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02459, USA
    Int J Radiat Oncol Biol Phys 70:1427-30. 2008
  2. ncbi request reprint Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast
    W Warren Suh
    Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 61:1054-61. 2005
  3. ncbi request reprint A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer
    W Warren Suh
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 62:790-6. 2005
  4. doi request reprint Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Radiat Oncol Biol Phys 77:1046-52. 2010
  5. pmc Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study
    Paul L Nguyen
    Harvard Radiation Oncology Program, Boston, MA 02115, USA
    Brachytherapy 8:345-52. 2009
  6. pmc Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, and Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Urol 188:1151-6. 2012
  7. ncbi request reprint Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study
    Paul L Nguyen
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    Cancer 110:1485-92. 2007
  8. pmc Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis
    David J Sher
    Harvard Radiation Oncology Program, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 74:440-6. 2009
  9. ncbi request reprint ACR Appropriateness Criteria on treatment of anal cancer
    Matthew M Poggi
    National Naval Medical Center, Department of Radiation Oncology, Bethesda, Md 20889 5000, USA
    J Am Coll Radiol 4:448-56. 2007
  10. doi request reprint Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 116:610-5. 2010

Detail Information

Publications17

  1. doi request reprint ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer
    W Warren Suh
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02459, USA
    Int J Radiat Oncol Biol Phys 70:1427-30. 2008
    ..A summary of the major randomized clinical trials spanning the past several decades is provided...
  2. ncbi request reprint Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast
    W Warren Suh
    Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 61:1054-61. 2005
    ..To assess the cost-effectiveness of radiation therapy (RT) in patients with ductal carcinoma in situ (DCIS) after breast-conserving surgery (BCS)...
  3. ncbi request reprint A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer
    W Warren Suh
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 62:790-6. 2005
    ..To assess, if and for whom, there are cost savings associated with alternate breast radiotherapy (RT) techniques when compared with the conventional external beam-based whole-breast RT with a boost (WBRT-B)...
  4. doi request reprint Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Radiat Oncol Biol Phys 77:1046-52. 2010
    ..RT alone in men with unfavorable risk localized prostate cancer (PCa), but it is unknown if this benefit applies to all risk subgroups and, in particular, the intermediate-risk group...
  5. pmc Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study
    Paul L Nguyen
    Harvard Radiation Oncology Program, Boston, MA 02115, USA
    Brachytherapy 8:345-52. 2009
    ..Patient-reported quality of life (QOL) after salvage brachytherapy for radiorecurrent prostate cancer has not been well-characterized prospectively...
  6. pmc Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, and Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Urol 188:1151-6. 2012
    ..We report updated results of magnetic resonance imaging guided partial prostate brachytherapy and propose a definition of biochemical failure following focal therapy...
  7. ncbi request reprint Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study
    Paul L Nguyen
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    Cancer 110:1485-92. 2007
    ....
  8. pmc Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis
    David J Sher
    Harvard Radiation Oncology Program, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 74:440-6. 2009
    ..We aim to determine the incremental cost-effectiveness of PBI compared with whole-breast radiation therapy (WBRT) for estrogen receptor-positive postmenopausal women treated for early-stage breast cancer...
  9. ncbi request reprint ACR Appropriateness Criteria on treatment of anal cancer
    Matthew M Poggi
    National Naval Medical Center, Department of Radiation Oncology, Bethesda, Md 20889 5000, USA
    J Am Coll Radiol 4:448-56. 2007
    ..To this end, anal cancer is a disease best treated primarily with chemoradiation. Although appropriate treatment can produce acceptable results, further investigation and improvement in therapy are still needed...
  10. doi request reprint Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 116:610-5. 2010
    ..Therefore, our ability to determine who would benefit from salvage hormonotherapy (HT) would be enhanced if an individual's risk of nonprostate-cancer-specific mortality were known...
  11. ncbi request reprint Long-term results of MRI-guided partial prostate brachytherapy for favorable-risk prostate cancer: Implications for focal therapy
    Paul Linh Nguyen
    Dana Farber Cancer Institute Brigham and Women s Hospital, Harvard Medical School, Boston, MA University of Connecticut, Storrs, CT Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA Cancer Center of Santa Barbara, Santa Barbara, CA
    J Clin Oncol 30:114. 2012
    ..To exclude benign PSA increases due to prostatic hyperplasia, PSA failure was defined as nadir + 2 with PSA velocity >0.75 ng/mL/year. Cox multivariable analysis was used to determine factors associated with PSA failure...
  12. doi request reprint Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices
    Robert A Cormack
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Int J Radiat Oncol Biol Phys 76:615-23. 2010
    ..We model this new approach for two types of treatment...
  13. doi request reprint Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer
    Ronald C Chen
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Cancer 116:1879-86. 2010
    ..The authors undertook the current study to assess the feasibility of incorporating PRO measurement into routine clinical practice and to describe the trajectory of symptom development during treatment...
  14. ncbi request reprint A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences
    W Warren Suh
    Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Breast J 10:204-10. 2004
    ..This novel approach suggests excellent local-regional control when compared to historical controls. A phase II trial is warranted...
  15. ncbi request reprint Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer
    Yonina R Murciano-Goroff
    Dana Farber Cancer Institute Brigham and Women s Hospital, Harvard Medical School, Boston, MA Brigham and Women s Hospita Harvard Medical School, Boston, MA Cancer Center of Santa Barbara, Santa Barbara, CA
    J Clin Oncol 30:249. 2012
    ....
  16. doi request reprint ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer
    Suzanne Russo
    Department of Radiation Oncology, University Hospitals Case Western Seidman Cancer Center, Cleveland, OH Department of Radiation Oncology, Wake Forest University, Winston Salem, NC Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, American Society of Clinical Oncology Cleveland Clinic, Cleveland, OH MD Anderson Cancer Center, Houston, TX, American College of Surgeons Memorial Sloan Kettering Cancer Center, New York, NY Massachusetts General Hospital, Boston, MA Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ University of Texas Health Science Center at San Antonio, San Antonio, TX The Chester County Hospital, West Chester, Pa Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA Department of Radiation Oncology, Johns Hopkins University, Baltimore, MD Stritch School of Medicine, Loyola University Chicago, Maywood, IL Knight Cancer Institute, Oregon Health and Science University, Portland, OR Cancer Center of Santa Barbara, Santa Barbara, CA
    Am J Clin Oncol 38:520-5. 2015
    ..Neoadjuvant radiation┬▒chemotherapy followed by LE in higher risk patients results in excellent local control, but it is not clear if this approach reduces recurrence rates over surgery alone. ..
  17. ncbi request reprint Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature
    Paul L Nguyen
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 110:1417-28. 2007
    ....